Danaher reported its third-quarter 2021 revenue at $7.2 billion, a 23% increase over the same period last year.
Latest In Danaher
The manufacturer reported a strong second quarter, as profit almost doubled to $1.7 billion.
Newly appointed EVP Jennifer L. Honeycutt will be responsible for a handful of Danaher's business divisions.
As part of the company’s previously disclosed succession plan, Blair is replacing retiring CEO Thomas P. Joyce Jr.
Company reports solid results; earnings rise 15 percent to $663.7 million.
Manufacturer reports strong second quarter, as earnings rise 20 percent.
IDT develops, manufactures and markets nucleic acid products.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Danaher names Matthew McGrew to succeed Daniel Comas as CFO.
Year-to-date, the manufacturer reported sales of $13.2 billion, up 7.3 percent.
Sales for the first half increased 6.7 percent year-over-year.
Year-over-year profit increased 9.7 percent for the first quarter.
For the first nine months, sales were up 21.6 percent year-over-year.
Cepheid will become part of the company's diagnostics segment.
